Opportunistic Infections (OIs) in Patients with Hematologic Malignancies (HM) Treated with Bruton’s Tyrosine Kinase (BTK) and Phosphoinositide 3 Kinase (PI3K) Inhibitors: An 8-Year Retrospective Cohort Study

BACKGROUND: BTK and PI3K inhibitors are increasingly used for treatment in patients with HM. OIs when these agents were used as first line therapy signaled an increased level of immunosuppression beyond what was expected from the mechanism of action of these drugs. The epidemiology of OIs in the set...

Descripción completa

Detalles Bibliográficos
Autores principales: Issa, Nicolas, Arbona-Haddad, Esther, Nevett-Fernandez, Alexandra, Prestes, Daniel, Liakos, Alexis, Woolley, Ann, Hammond, Sarah, Brown, Jennifer, Baden, Lindsey, Marty, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631371/
http://dx.doi.org/10.1093/ofid/ofx163.1876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631371/
http://dx.doi.org/10.1093/ofid/ofx163.1876

Ejemplares similares